Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Press Release : FDA accepts application for -3-

07/29/2021 | 01:03am EDT

Phone: +41 61 688 8888 / e-mail: media.relations@roche.com https://www.globenewswire.com/Tracker?data=voTpyWPtVaHiMtrNEt2lX_4uJBj_w-UvOJnv0c4uiw763uQfK4rmzkQkJhax5lUGNkOn9gC2kFA5LgWP8U-VDpdNKofXwEJ70eRQ6PX56Ns1o1YfOwVHz11BImaoHdPa

 
Dr. Nicolas Dunant          Patrick Barth 
 Phone: +41 61 687 05 17     Phone: +41 61 688 44 86 
Dr. Barbara von Schnurbein  Karsten Kleine 
 Phone: +41 61 687 89 67     Phone: +41 61 682 28 31 
Nina Mählitz           Nathalie Meetz 
 Phone: +41 79 327 54 74     Phone: +41 61 687 43 05 
 
 
Roche Investor Relations 
Dr. Karl Mahler                        Jon Kaspar Bayard 
 Phone: +41 61 68-78503                 Phone: +41 61 68-83894 
 e-mail: karl.mahler@roche.com          e-mail: jon_kaspar.bayard@roche.com 
Dr. Sabine Borngräber             Dr. Bruno Eschli 
 Phone: +41 61 68-88027                 Phone: +41 61 68-75284 
 e-mail: sabine.borngraeber@roche.com   e-mail: bruno.eschli@roche.com 
Dr. Birgit Masjost                     Dr. Gerard Tobin 
 Phone: +41 61 68-84814                 Phone: +41 61 68-72942 
 e-mail: birgit.masjost@roche.com       e-mail: gerard.tobin@roche.com 
 
Investor Relations North America 
Loren Kalm 
 Phone: +1 650 225 3217 
 e-mail: kalm.loren@gene.com 
 

Attachment

   -- 29072021_MR_faricimab 
      https://ml-eu.globenewswire.com/Resource/Download/298f819a-bfa3-479e-bfbf-3cb8299a85f8 
 
 
 

(END) Dow Jones Newswires

July 29, 2021 01:03 ET (05:03 GMT)

All news about ROCHE HOLDING AG
01:29aROCHE : Drug Halts Tumor Proliferation in Mid-Stage Breast Cancer Study
MT
01:12aROCHE : presents first phase II data on giredestrant, a next generation selectiv..
PU
09/15China's biotech sector comes of age with big licensing deals, global ambition..
RE
09/15ROCHE HOLDINGS AG : Receives a Buy rating from Deutsche Bank
MD
09/15ROCHE HOLDINGS AG : JP Morgan reaffirms its Neutral rating
MD
09/15ROCHE : Launches Open Access Digital Pathology Platform
MT
09/15ROCHE : opens access to pathology imaging tools to improve patient care
AQ
09/15PRESS RELEASE : Roche opens access to pathology imaging tools to improve patient..
DJ
09/15Roche Opens Access to Pathology Imaging Tools to Improve Patient Care
CI
09/15ROCHE : To Continue Developing COVID-19 Therapies, Diagnostics Amid Endemic Poss..
MT
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2021 61 302 M 66 121 M 66 121 M
Net income 2021 14 713 M 15 870 M 15 870 M
Net cash 2021 4 900 M 5 286 M 5 286 M
P/E ratio 2021 20,1x
Yield 2021 2,72%
Capitalization 303 B 327 B 326 B
EV / Sales 2021 4,86x
EV / Sales 2022 4,72x
Nbr of Employees 101 465
Free-Float 83,5%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 345,15 CHF
Average target price 384,23 CHF
Spread / Average Target 11,3%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG11.70%327 062
JOHNSON & JOHNSON4.98%435 465
PFIZER, INC.21.62%251 011
NOVO NORDISK A/S49.16%231 607
ELI LILLY AND COMPANY36.84%211 895
ABBVIE INC.0.87%190 449